Lixte Biotechnology Holdings, Inc. (LIXT) delivered a return of 690.56% over the past year. Since LIXT does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Lixte Biotechnology Holdings, Inc. one year ago would be worth $79,056 today, representing a gain of $69,056.

Lixte Biotechnology Holdings, Inc. (LIXT) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For LIXT, the total return equals the price-only return.

Yes, Lixte Biotechnology Holdings, Inc. (LIXT) outperformed the S&P 500 by 669.72 percentage points over the past year. LIXT delivered a total return of 690.56%, compared to the S&P 500's 20.84%. This 669.72pp alpha means investors in LIXT earned more than a passive S&P 500 index fund.

Lixte Biotechnology Holdings, Inc. (LIXT) experienced a maximum drawdown of -58.24% over the past year, declining from its peak on 2025-09-12 to its trough on 2026-03-06. The stock recovered to its prior peak by 2026-05-27. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Lixte Biotechnology Holdings, Inc. (LIXT)'s long-term returns with dividends reinvested. Over 10 years, the total return is -42.7% (-5.4% CAGR) — $10,000 would have grown to $5,725. Over 20 years: -99.7% total return (-25.8% CAGR) — $10,000 → $25. Over 30 years: -99.7% total return (-18.1% CAGR) — $10,000 → $25. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Lixte Biotechnology Holdings, Inc.'s best calendar year was 2018 with a total return of 447.1%. Its worst year was 2010 with a total return of -92.9%. This range shows the volatility investors should expect — the difference between the best and worst year is 539.9 percentage points.